Aion Therapeutic Inc. (ANTCF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Aion Therapeutic Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.84
Burn Risk
P/B Ratio
-1.37
Equity Deficit
Earnings Yield
-118.59%
Yield Gap
Profitability Health
2024Return on Equity
162.38%
Strong
WeakModerateStrong
Operating Margin
-324.09%
Weak
WeakModerateStrong
Net Profit Margin
-1710.90%
Weak
WeakModerateStrong
Growth Indicators
2024Revenue Growth
-
No data
Net Income Growth
-2349.64%
Weak
WeakModerateStrong
EPS Growth
-1216.67%
Weak
WeakModerateStrong
Efficiency & Liquidity
2024Current Ratio
0.12
Weak
WeakModerateStrong
Quick Ratio
0.03
Weak
WeakModerateStrong
Asset Turnover
0.52x
Moderate
WeakModerateStrong
Inventory Turnover
0.51x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-15.94%
Weak
WeakModerateStrong
EV / Free Cash Flow
-8.66x
Strong
WeakModerateStrong
Net Debt / EBITDA
-0.33x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
5.279
Strong
WeakModerateStrong
Return on Invested Capital
66.52%
Strong
WeakModerateStrong
Cash Conversion Cycle
-3299.02 days
Strong
WeakModerateStrong
Fortress screener guardrails
3/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for ANTCF.
View Financial Statements